Tuberculosis: Promising new tuberculosis drug pretomanid approved, but will it be affordable?
August 15, 2019GENEVA/NEW YORK – Doctors Without Borders/Médecins Sans Frontières (MSF) welcomes the approval by the US Food and Drug Administration (FDA) of a combination regimen containing a new drug, pretomanid, for the treatment of extensively drug-resistant tuberculosis (XDR-TB). As the third...
Read more
